Tolinapant modulates therapeutic response to radiation in high-risk prostate cancer through inhibition of anti-apoptosis proteins

Activity: Talk or presentation typesOral presentation

Description

Oral Poster Presentation in consideration for the Professor John Fitzpatrick medal
Period07 Mar 2025
Event titleIrish Association for Cancer Research 2025 Annual Conference
Event typeConference
LocationUnited KingdomShow on map
Degree of RecognitionInternational